Boston Scientific Statistics

Total Valuation

ETR:BSX has a market cap or net worth of EUR 136.07 billion. The enterprise value is 145.94 billion.

Market Cap	136.07B
Enterprise Value	145.94B

Important Dates

The next estimated earnings date is Wednesday, July 23, 2025.

Earnings Date	Jul 23, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	1.48B
Shares Outstanding	n/a
Shares Change (YoY)	+1.11%
Shares Change (QoQ)	+0.19%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	1.48B

Valuation Ratios

The trailing PE ratio is 72.37 and the forward PE ratio is 35.11.

PE Ratio	72.37
Forward PE	35.11
PS Ratio	8.38
PB Ratio	6.55
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 35.78, with an EV/FCF ratio of 52.33.

EV / Earnings	77.63
EV / Sales	9.45
EV / EBITDA	35.78
EV / EBIT	51.08
EV / FCF	52.33

Financial Position

The company has a current ratio of 1.45, with a Debt / Equity ratio of 0.52.

Current Ratio	1.45
Quick Ratio	0.68
Debt / Equity	0.52
Debt / EBITDA	2.53
Debt / FCF	3.88
Interest Coverage	10.21

Financial Efficiency

Return on equity (ROE) is 9.50% and return on invested capital (ROIC) is 6.21%.

Return on Equity (ROE)	9.50%
Return on Assets (ROA)	5.28%
Return on Invested Capital (ROIC)	6.21%
Return on Capital Employed (ROCE)	9.25%
Revenue Per Employee	306,433
Profits Per Employee	35,472
Employee Count	53,000
Asset Turnover	0.46
Inventory Turnover	2.04

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +34.31% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+34.31%
50-Day Moving Average	89.87
200-Day Moving Average	86.26
Relative Strength Index (RSI)	49.03
Average Volume (20 Days)	115

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.01

Income Statement

In the last 12 months, ETR:BSX had revenue of EUR 16.24 billion and earned 1.88 billion in profits. Earnings per share was 1.27.

Revenue	16.24B
Gross Profit	11.12B
Operating Income	3.00B
Pretax Income	2.29B
Net Income	1.88B
EBITDA	4.20B
EBIT	3.00B
Earnings Per Share (EPS)	1.27

Full Income Statement

Balance Sheet

The company has 670.77 million in cash and 10.83 billion in debt, giving a net cash position of -10.16 billion.

Cash & Cash Equivalents	670.77M
Total Debt	10.83B
Net Cash	-10.16B
Net Cash Per Share	n/a
Equity (Book Value)	20.77B
Book Value Per Share	13.89
Working Capital	2.11B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 3.53 billion and capital expenditures -738.31 million, giving a free cash flow of 2.79 billion.

Operating Cash Flow	3.53B
Capital Expenditures	-738.31M
Free Cash Flow	2.79B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 68.45%, with operating and profit margins of 18.49% and 11.58%.

Gross Margin	68.45%
Operating Margin	18.49%
Pretax Margin	14.12%
Profit Margin	11.58%
EBITDA Margin	25.84%
EBIT Margin	18.49%
FCF Margin	17.17%

Dividends & Yields

ETR:BSX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.11%
Shareholder Yield	n/a
Earnings Yield	1.38%
FCF Yield	2.05%

Stock Splits

The last stock split was on November 6, 2003. It was a forward split with a ratio of 2.

Last Split Date	Nov 6, 2003
Split Type	Forward
Split Ratio	2

Scores

ETR:BSX has an Altman Z-Score of 5.13.

Altman Z-Score	5.13
Piotroski F-Score	n/a